Earnings History Data for Spectrum Pharmaceuticals (SPPI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-05-2023	PM	Before the open (May 9)	SPPI	Spectrum Pharmaceuticals	224.00	-0.02	-0.05	0.00		1.20	0.09 (8.64%)	1.17	0.07 (6.36%)	0.31 - 1.57	10,216,515	6,420,000	1,116,501
Spectrum Pharmaceuticals rises as co. says its Q1 net sales up 54% Q/Q [5/9/2023 9:12 AM]
22-03-2023	PM	Before the open (Mar 22)	SPPI	Spectrum Pharmaceuticals, Inc.	159.13	-0.06	-0.09	-0.26	Spectrum Pharmaceuticals GAAP EPS of -$0.06 beats by $0.05, revenue of $10.1M beats by $0.3M [3/22/2023 8:03 AM]	0.7299	-0.10 (-11.59%)	0.86	0.03 (4.17%)	0.31 - 1.57	3,903,210	1,190,000	380,720
Spectrum Pharmaceuticals Q4 2022 Earnings Preview [3/21/2023 12:19 PM] Spectrum Pharmaceuticals GAAP EPS of -$0.06 beats by $0.05, revenue of $10.1M beats by $0.3M [3/22/2023 8:03 AM]
10-11-2022	AH	4:00 PM ET (Nov 10)	SPPI	Spectrum Pharmaceuticals, Inc.	79.54	-0.12	-0.15	-0.21	Spectrum Pharmaceuticals GAAP EPS of -$0.12 beats by $0.03 [11/10/2022 4:10 PM]	0.4788	0.02 (3.57%)	0.45	-0.01 (-2.66%)	0.36 - 2.11	1,829,117	1,320,000	57,723
Spectrum Pharmaceuticals GAAP EPS of -$0.12 beats by $0.03 [11/10/2022 4:10 PM] Spectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-10-22 04:05PM]
11-08-2022	PM	7:20 AM ET (Aug 11)	SPPI	Spectrum Pharmaceuticals, Inc.	151.29	-0.17	-0.16	-0.32	Spectrum Pharmaceuticals GAAP EPS of -$0.17 misses by $0.02 [8/11/2022 8:04 AM]	1.21	0.09 (7.59%)	1.22	0.10 (8.93%)	0.60 - 2.53	3,106,175	2,110,000	620,825
Spectrum Pharmaceuticals Q2 2022 Earnings Preview [8/10/2022 1:28 PM] Spectrum Pharmaceuticals GAAP EPS of -$0.17 misses by $0.02 [8/11/2022 8:04 AM] Spectrum Pharma rises 9% after FDA completes re-inspection of manufacturing facility for eflapegrastim drug [8/11/2022 12:52 PM] Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-11-22 08:00AM]
12-05-2022	AH	4:00 PM ET (May 12)	SPPI	Spectrum Pharmaceuticals, Inc.	147.89	-0.09	-0.18	-0.25	Spectrum Pharmaceuticals Non-GAAP EPS of -$0.06 [5/12/2022 4:02 PM]	0.7799	0.03 (3.99%)	0.80	0.05 (6.67%)	0.60 - 4.54	1,926,200	2,030,000	21,233
Spectrum Pharmaceuticals Non-GAAP EPS of -$0.06 [5/12/2022 4:02 PM] Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer [May-11-22 07:00AM] Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-12-22 04:00PM] Spectrum Pharmaceuticals (SPPI) Q1 2022 Earnings Call Transcript [May-13-22 12:00AM]
17-03-2022	AH	4:00 PM ET (Mar 17)	SPPI	Spectrum Pharmaceuticals, Inc.	129.20	-0.26	-0.21	-0.36	Spectrum Pharmaceuticals Non-GAAP EPS of -$0.17 beats by $0.01 [3/17/2022 4:05 PM]	0.9244	0.07 (8.79%)	0.87	0.02 (2.39%)	0.60 - 4.54	2,768,380	4,951,249	31,309
Spectrum Pharmaceuticals Non-GAAP EPS of -$0.17 beats by $0.01 [3/17/2022 4:05 PM] Spectrum Pharmaceuticals down 2% post-market despite Q4 2021 earnings beat [3/17/2022 4:34 PM] Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update [Mar-17-22 04:00PM] HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock [Mar-18-22 02:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	SPPI	Spectrum Pharmaceuticals, Inc.	362.60	-0.21	-0.30	-0.37	Spectrum Pharmaceuticals EPS beats by $0.09, misses on revenue [11/10/2021 4:04 PM]	2.05	0.01 (0.25%)	2.09	0.05 (2.45%)	1.79 - 5.24	1,760,705	2,740,000	12,723
Spectrum Pharmaceuticals EPS beats by $0.09, misses on revenue [11/10/2021 4:04 PM] Spectrum Pharma up 5% after-hours following quarterly earnings beat [11/10/2021 5:18 PM] Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update [Nov-10-21 04:00PM] Spectrum Pharmaceuticals, inc (SPPI) Q3 2021 Earnings Call Transcript [Nov-10-21 08:30PM] Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference [Nov-11-21 07:00AM]
12-08-2021	AH	4:00 PM ET (Aug 12)	SPPI	Spectrum Pharmaceuticals, Inc.	392.00	-0.32	-0.24	0.00	Spectrum Pharmaceuticals EPS misses by $0.06 [8/12/2021 4:17 PM]	2.25	-0.10 (-4.26%)	2.31	-0.04 (-1.70%)	2.21 - 5.24	3,964,947	4,830,000	14,490
Spectrum Pharmaceuticals EPS misses by $0.06 [8/12/2021 4:17 PM] Spectrum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Update [Aug-12-21 04:05PM] SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI [Aug-11-21 05:37PM] Spectrum Pharmaceuticals, inc (SPPI) Q2 2021 Earnings Call Transcript [Aug-12-21 08:30PM]
13-05-2021	AH	4:00 PM ET (May 13)	SPPI	Spectrum Pharmaceuticals, Inc.	485.83	-0.25	-0.33	-0.36	Spectrum Pharmaceuticals EPS in-line [5/13/2021 4:03 PM]	3.48	0.42 (13.73%)	3.08	0.02 (0.65%)	2.68 - 5.24	3,969,946	2,420,000	2,024
Spectrum Pharmaceuticals EPS in-line [5/13/2021 4:03 PM] Spectrum Pharmaceuticals, Inc. to Host Earnings Call [May-13-21 02:30PM] Spectrum Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Update [May-13-21 04:00PM] Spectrum Pharmaceuticals Inc (SPPI) Q1 2021 Earnings Call Transcript [May-13-21 08:30PM]
04-11-2020	AH		SPPI	Spectrum Pharmaceuticals, Inc.	508.61	-0.37	-0.37	-0.22	Spectrum Pharmaceuticals EPS misses by $0.02 [11/4/2020 4:03 PM]	3.58	-0.10 (-2.72%)	3.60	-0.08 (-2.17%)	1.74 - 10.57	1,590,457	2,179,471	4,562

10-08-2020	AH	4:00 PM ET (Aug 10)	SPPI	Spectrum Pharmaceuticals, Inc.	555.55	-0.29	-0.33	-0.26	Spectrum Pharmaceuticals EPS beats by $0.03 [8/10/2020 4:07 PM]	3.99	0.06 (1.60%)	4.01	0.08 (2.04%)	1.74 - 10.57	1,831,664	7,079,264	13,499